The comparison exposes cracks in US healthcare, where the focus is more on treatment than prevention, says Rishi Wadhera.

Past research has shown that sexual-minority people have a heightened risk of CVD, especially when they also belong to other ...

Part of the benefit may be due to BP-lowering effects of the drug and/or fewer abnormal heart rhythms, says Seemant ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.